The epidemiology and therapeutic options for the COVID-19

Jingwei Li1, Jun Shao1, Chengdi Wang1

  • 1Department of Respiratory and Critical Care Medicine, West China Medical School/West China Hospital, Sichuan University, Chengdu 610041, China.

Insights

This review summarizes the latest research on coronavirus disease 2019 (COVID-19), covering its virology, epidemiology, clinical features, and treatments. It also explores asymptomatic carriers to aid in combating the global pandemic.

Area of Science:

  • * Infectious Diseases
  • * Virology
  • * Epidemiology

Background:

  • * The emergence of coronavirus disease 2019 (COVID-19) represents a significant global health crisis.
  • * COVID-19 is the third major coronavirus epidemic in the 21st century, following SARS and MERS.
  • * The World Health Organization (WHO) has declared COVID-19 a global pandemic due to its widespread impact.

Purpose of the Study:

  • * To provide a comprehensive overview of the current understanding of COVID-19.
  • * To review advances in the virology, epidemiology, clinical characteristics, and therapeutic strategies for COVID-19.
  • * To explore the role and implications of asymptomatic carriers in disease transmission.

Main Methods:

  • * Literature review of recent scientific publications and research findings.
  • * Synthesis of data on COVID-19 virology and epidemiology.
  • * Analysis of clinical features, treatment options, and prevention strategies.

Main Results:

  • * Detailed insights into the novel pneumonia virus causing COVID-19.
  • * Epidemiological data highlighting the global spread and impact of the pandemic.
  • * Summary of current therapeutic options and preventive measures, including the study of asymptomatic transmission.

Conclusions:

  • * A thorough understanding of COVID-19's multifaceted aspects is crucial for effective pandemic control.
  • * Continued research into pathophysiology, clinical management, and asymptomatic transmission is essential.
  • * The findings support ongoing global efforts to combat the COVID-19 pandemic through informed strategies.

Related Concept Videos

Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
435
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
255
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
229
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
14
Transmission-based Precautions I: Contact, Enteric, and Droplets01:17

Transmission-based Precautions I: Contact, Enteric, and Droplets

Transmission-based precautions are for patients known to be infected or suspected to be infected or colonized with organisms that pose a significant risk to others. Some transmission-based precautions include contact, enteric, and droplet.
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
3.9K
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
2.7K